News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
News|Videos|October 25, 2017

Why Look for Molecular Markers?

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Dr. Nabil Rizk

Expert Explains Recent Advances in Early Stage Lung Cancer Surgery

BySpencer Feldman
November 25th 2025
Image of woman.

How I Navigate Grief and the Holidays After Cancer Loss

ByGeorgia Hurst
November 24th 2025
lung image

How New Therapies Are Changing the Game for Small Cell Lung Cancer

BySpencer Feldman
November 24th 2025
The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients with polycythemia vera.

SANRECO Trial Explores Divesiran for Polycythemia Vera Treatment

ByAlex Biese
November 24th 2025
brain image

Voranigo is Safe and Tolerable in High-Grade IDH-Mutant Gliomas

ByRyan Scott
November 24th 2025
Advertisement
Advertisement

Trending on CURE

1

Sac-TMT Combo Shows Benefit in Advanced Lung Cancer Treatment

2

How New Therapies Are Changing the Game for Small Cell Lung Cancer

3

Connecting With Multiple Myeloma Support Groups and Online Resources

4

Imbruvica Plus Drug Combo Shows Strong Responses in Newly Diagnosed PCNSL

5

Voranigo is Safe and Tolerable in High-Grade IDH-Mutant Gliomas

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.